Characterization and pathogenicity of Rhizoctonia isolates collected from Brassica oleracea var. acephala in Ordu, Turkey
Sign Up to like & getrecommendations! Published in 2020 at "Phytoparasitica"
DOI: 10.1007/s12600-020-00793-9
Abstract: A total of 30 Rhizoctonia isolates were collected from plants with Rhizoctonia-like symptoms in kale growing areas in Ordu province during the 2014–2015 growing seasons. All the isolates were identified using nuclear staining tecnique and… read more here.
Keywords: rhizoctonia isolates; rcb rcb; isolates collected; pathogenicity ... See more keywords
Abstract RF3-05: A Phase 2 Study of Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP)
Sign Up to like & getrecommendations! Published in 2025 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.sabcs24-rf3-05
Abstract: Background: Immune checkpoint inhibition (ICI) is synergistic with HER2-directed therapy in pre-clinical models. Clinically, pembrolizumab (K)-mediated ICI in addition to HER2-directed therapy with trastuzumab (H) was safe and demonstrated modest activity in H-resistant HER2-positive (HER2+)… read more here.
Keywords: cancer; therapy; her2; rcb rcb ... See more keywords
HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.502
Abstract: 502 Background: HER2 targeted therapy without chemotherapy may be insufficient to completely eradicate a HER2+ cancer in cases of significant intratumor HER2 heterogeneity (ITH-HER2). Methods: We conducted a single-arm phase II study enrolling centrally confirmed… read more here.
Keywords: ith her2; rcb rcb; response; her2 ... See more keywords